Search Results
- < Prev
1 of 1
- Next >
News Releases
-
May 15, 2013, 07:00 ET
Auxilium Pharmaceuticals, Inc. To Present At The UBS Global Health Care Conference
Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL) today announced that executive management will participate in the UBS Global Health Care Conference to be held May 20-22 at the Sheraton New York Hotel. Mr. Adrian Adams, Chief Executive Officer and President, is scheduled to present an...
More news about: Auxilium Pharmaceuticals, Inc. , UBS Global Health Care Conference
-
May 10, 2013, 16:43 ET
Auxilium Pharmaceuticals, Inc. To Present At The Bank Of America Merrill Lynch 2013 Health Care Conference
Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL) today announced that executive management will participate in the Bank of America Merrill Lynch 2013 Health Care Conference to be held May 14-16 at the Encore at the Wynn Las Vegas. Mr. Adrian Adams, Chief Executive Officer and President, is...
More news about: Auxilium Pharmaceuticals, Inc. , Bank of America Merrill Lynch 2013 Health Care Conference
-
Apr 29, 2013, 07:00 ET
Auxilium Pharmaceuticals Completes Acquisition Of Actient Holdings LLC To Create A Leading Urology Franchise With A Diversified Product Portfolio And Strong Growth Profile
Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced that it has completed the acquisition of Actient Holdings LLC ("Actient"), a private urology specialty therapeutics company, for $585 million in upfront cash plus certain contingent...
More news about: Auxilium Pharmaceuticals, Inc. , Actient Holdings LLC
-
Apr 29, 2013, 07:00 ET
Auxilium Pharmaceuticals, Inc, Announces First Quarter 2013 Financial Results
Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL), a specialty biopharmaceutical company, today announced financial results for the first quarter ending on March 31, 2013. The Company also highlighted important recent commercial, regulatory and clinical development progress in the first quarter...
More news about: Auxilium Pharmaceuticals, Inc.
-
Apr 25, 2013, 16:27 ET
Auxilium Pharmaceuticals to Announce First Quarter 2013 Results and Conduct Conference Call on Monday, April 29, 2013
Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, will release results for the first quarter 2013 on Monday, April 29, 2013 before the opening of the U.S. financial markets. The Company will also conduct a conference call that day at 8:30 a.m. ET to discuss...
More news about: Auxilium Pharmaceuticals, Inc.
-
Mar 26, 2013, 08:00 ET
BioSpecifics Technologies Corp. Announces Positive Top-line Data from XIAFLEX® Phase IIa Study for Frozen Shoulder
BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® in the U.S., today announced positive, statistically significant top-line data from the Phase IIa study of XIAFLEX for the potential...
More news about: BioSpecifics Technologies Corp. , Auxilium Pharmaceuticals, Inc.
- < Prev
1 of 1
- Next >
Modify your Search
 |
Quickly search for PR Newswire releases by adding our plugin to your browser search |